MA 2029 |
| Catalog No.GC14467 |
motilin receptor antagonist,potent and selective
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 287206-61-5
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 287206-61-5 | SDF | |
| Chemical Name | (S,Z)-N-((S,Z)-3-(3-(tert-butyl)-4-hydroxyphenyl)-1-(ethylimino)-1-hydroxypropan-2-yl)-2-((S)-3-(4-fluorophenyl)-N-methyl-2-(methylamino)propanamido)-3-methylbutanimidic acid | ||
| Canonical SMILES | CC/N=C(O)/[C@](/N=C(O)/[C@](N(C([C@](NC)([H])CC1=CC=C(F)C=C1)=O)C)([H])C(C)C)([H])CC2=CC(C(C)(C)C)=C(O)C=C2 | ||
| Formula | C31H45FN4O4 | M.Wt | 556.71 |
| Solubility | <11.13mg/ml in 1eq. HCl; <55.67mg/ml in DMSO | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.7963 mL | 8.9813 mL | 17.9627 mL |
| 5 mM | 0.3593 mL | 1.7963 mL | 3.5925 mL |
| 10 mM | 0.1796 mL | 0.8981 mL | 1.7963 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC11307 ML-264
- GC40481 Propyl Gallate
- GC43947 JWH 018 N-pentanoic acid metabolite
- GC14966 8-Hydroxy-DPAT hydrobromide
- GC13504 NHS-Biotin
- GC41980 18-carboxy dinor Leukotriene B4
- GC39235 PEG5-Tos
- GC39533 Cinnamoylglycine
- GC38642 PACAP-38 (31-38), human, mouse, rat TFA
- GC41491 Hecogenin
- GC32878 Fumarate hydratase-IN-1
- GC18763 TN-16
- GC32989 Pyrotinib dimaleate (SHR-1258 dimaleate)
- GC10141 Bay 36-7620
- GC35720 Colivelin TFA
- GC17412 Deferasirox Fe3+ chelate
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *